Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of BI 1060469 and BI 1021958 on GFR in Healthy Males
NCT02202512Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of BI 1060469 and bi 1021958 in asthma (5 arms), sponsored by Boehringer Ingelheim. Primary endpoint: measured glomerular filtration rate. Started Sep 2014; status: completed.
02
Drugs
BI 1060469bi 1021958
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02202512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02202512.